Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (17780)	3/22/1998 8:16:00 AM
From: Wallace Rivers	Respond to of 32384

To open, I would like you to know I am poorly versed in the science of biotech compared to virtually all of the thread participants - I am a mere investor trying to make a buck! That being said, these are the reasons I am bullish on LGND: 1. Much better than anticipated earnings (small loss) last Q, which will probably lead to profitability earlier than analysts were expecting. 2. A pipeline which has been described to me as one of the best in the business. 3. Strategic relationships with a multitude of the major pharmas. 4. Very good financial position, with a substantial cash position. I believe the amount of cash in the till is more or less unchanged from when I started following LGND more than 3 years ago. For a start up biotech enterprise, that is impressive, and also shows the belief major partners have in LGND's science (by opening up their pocketbooks).